Botanical species · safety record

Ocimum tenuiflorum

The EFSA Compendium of Botanicals holds 2 constituent measurements and 1 adverse-effect record for Ocimum tenuiflorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ocimum tenuiflorum L.

2Constituent measurements

1Safety records

3Cited sources

553Licensed products (Canada)

Also recorded as

Ocimum sanctum L.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 553 licensed products naming Ocimum tenuiflorum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Aerial parts
Fruit
Herb
Herb top
Leaf
Leaf extract
Leaf young
Leaves

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Eugenol	Leaves	Solvent extraction	—	LC-MS	No resolvable identifier
Methyleugenol	Live plants	Solvent extraction	—	LC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Testes	Leaves	Solvent extraction	House mouse (as animal)	Reproduction toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Pragya, S., Hembrom, A.R., Singh, V.N. Antifertility efficacy of aqueous leaf extract of Ocimum sanctum (Linn) on seminal LDH isozymes of mice. Journal of advanced zoology, 2013, vol. 34, no. 1, p. 36-39.
Dutta, Dipanwrta., Devi, S. Saravana., Krishnamurthi, K., Kumar, Koel., Vyas, Priyanka., Muthal, P. L., Naoghare, P., Chakrabarti, T. Modulatory effect of distillate of Ocimum sanctum leaf extract (Tulsi) on human lymphocytes against genotoxicants . Biomedical and environmental sciences, 2007, vol. 20, no. 3, p. 226-234.
Kaewnarin, Khwanta., Rakariyatham, Nuansri. Inhibitory Effects of Phenolic Compounds in Ocimum sanctum Extract on the alpha-Glucosidase Activity and the Formation of Advanced Glycation End-products . Chiang mai journal of science, 2017, vol. 44, no. 1, p. 203-214.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature